Ascentage Pharma Group International (AAPG) Shares Outstanding (2022 - 2025)

Ascentage Pharma Group International (AAPG) has reported Shares Outstanding (Entity) for 4 consecutive years, with $52.6 million the latest figure, recorded in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 8.56% year-over-year to $52.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $52.6 million (up 8.56% YoY) and the FY2025 annual result came in at $51.9 million, up 7.15% from the prior year.
• Shares Outstanding (Entity) rose to $52.6 million in Q4 2025 per AAPG's latest filing, from $48.5 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for AAPG reached as high as $52.6 million in Q4 2025 and fell as low as $37.3 million in Q4 2022.
• A 4-year average of $44.7 million and a median of $44.4 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) gained 8.1% — and 2024, when it climbed 20.29%.
• Year by year, Shares Outstanding (Entity) stood at $37.3 million in 2022, then climbed by 8.1% to $40.3 million in 2023, then advanced by 20.29% to $48.5 million in 2024, then grew by 8.56% to $52.6 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $52.6 million, $48.5 million, and $40.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.